Discover the importance of a multistakeholder approach in NAFLD care, addressing the challenges of comorbidities, patient identification, and innovative strategies to improve treatment outcomes and healthcare coordination.
Explore with the slides the significance of a multistakeholder approach in NAFLD care as it tackles the complexities of comorbidities, patient detection, and groundbreaking tactics to enhance treatment results and healthcare collaboration.
Dr. Jörn Schattenberg (Germany) analyses the latest on the assessment in cirrhosis along with his own case study.
Prof Schattenberg, Germany, reviews how NASH impacts quality of life. He presents the mechanisms underlying metabolic comorbidities in NASH and discusses the relevant NASH phenotypes.